Skip to main content
Log in

Prognostic Significance of the Metastatic Lymph Node Ratio in Gastric Cancer Patients

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Background

Lymph node metastasis is considered one of the most important prognostic factors in gastric cancer. However, the optimal system for accurate staging of lymph node metastasis for patients with gastric cancer remains controversial. This study was designed to investigate the prognostic significance of the metastatic lymph node ratio (MLR), which is calculated by dividing the number of metastatic lymph nodes by the total number of nodes harvested from patients with gastric cancer.

Methods

We retrospectively analyzed the clinical data of 186 consecutive patients diagnosed with gastric cancer who underwent curative gastrectomy at our hospital. The lymph node status was classified according to three systems: the International Union Against Cancer/American Joint Committee on Cancer (UICC/AJCC) system; the Japanese Gastric Cancer Association (JGCA) system; and an MLR-based system (MLR0: 0, MLR1: 0.01–0.19, MLR2: ≥0.2). The influence of the MLR on patient survival was determined using univariate Kaplan-Meier survival analysis, the generalized Wilcoxon test, and analysis with the multivariate Cox proportional hazards model.

Results

The 5-year survival rate of the patients with MLR0, MLR1, and MLR2 was 88.6%, 59.4%, and 13.4%, respectively. In addition to the MLR, the UICC/AJCC N category, JGCA n category, tumor stage (pT category), and tumor diameter significantly influenced the 5-year survival rate, as determined by univariate analysis. Multivariate analyses revealed that of the three factors used to stage lymph node involvement, MLR was the most significant prognostic factor.

Conclusions

The MLR is an important and easy-to-assess prognostic factor that should be considered for staging lymph node metastasis in patients with gastric cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Adachi Y, Kamakura T, Mori M et al (1994) Prognostic significance of the number of positive lymph nodes in gastric carcinoma. Br J Surg 81:414–416

    Article  PubMed  CAS  Google Scholar 

  2. Yokota T, Ishiyama S, Saito T et al (2004) Lymph node metastasis as a significant prognostic factor in gastric cancer: a multi logistic regression analysis. Scand J Gastroenterol 39:380–384

    Article  PubMed  CAS  Google Scholar 

  3. Wu ZY, Li JH, Abe S et al (2007) Effect of lymph node micrometastases on prognosis of gastric carcinoma. World J Gastroenterol 13:4122–4125

    PubMed  CAS  Google Scholar 

  4. Japanese Gastric Cancer Association (1998) Japanese classification of gastric carcinoma, 2nd English edition. Gastric Cancer 1:10–24

    Article  PubMed  Google Scholar 

  5. Sobin LH, Fleming ID (1997) TNM classification of malignant tumors, Fifth edition Union Internationale Contre le Cancer and American Joint Committee on Cancer. Cancer 80:1803–1804

    Article  PubMed  CAS  Google Scholar 

  6. Nitti D, Marchet A, Olivieri M et al (2003) Ratio between metastatic and examined lymph nodes is an independent prognostic factor after D2 resection for gastric cancer: analysis of a large European monoinstitutional experience. Ann Surg Oncol 10:1077–1085

    Article  PubMed  Google Scholar 

  7. Bando E, Yoneyama Y, Taniguchi K et al (2002) Outcome of ratio of lymph node metastasis in gastric carcinoma. Ann Surg Oncol 9:775–784

    Article  PubMed  Google Scholar 

  8. Inoue K, Nakane Y, Iiyama H et al (2002) The superiority of ratio-based lymph node staging in gastric carcinoma. Ann Surg Oncol 9:27–34

    Article  PubMed  Google Scholar 

  9. Ozgüc H, Sönmer Y, Yerci O (2008) Metastatic/resected lymph nodes ratio-based classification in gastric cancer. Turk J Gastroenterol 19:2–7

    PubMed  Google Scholar 

  10. Saito H, Fukumoto Y, Osaki T et al (2008) Prognostic significance of the ratio between metastatic and dissected lymph nodes (n ratio) in patients with advanced gastric cancer. J Surg Oncol 97:132–135

    Article  PubMed  Google Scholar 

  11. Persiani R, Rausei S, Biondi A et al (2008) Ratio of metastatic lymph nodes: impact on staging and survival of gastric cancer. Euro J Surg Oncol 34:519–524

    CAS  Google Scholar 

  12. Huang CM, Lin BJ, Lu HS et al (2008) Prognostic impact of metastatic lymph node ratio in advanced gastric cancer from cardia and fundus. World J Gastroenterol 14:4383–4388

    Article  PubMed  Google Scholar 

  13. Yamaguchi T (2003) JGCA gastric cancer treatment guideline: a new trend in gastric cancer treatment. Jpn Medical Association J 46:238–245

    Google Scholar 

  14. Ichikura T, Tomimatsu S, Uefuji K et al (1999) Evaluation of the New American Joint Committee on Cancer/International Union against cancer classification of lymph node metastasis from gastric carcinoma in comparison with the Japanese classification. Cancer 86:553–558

    Article  PubMed  CAS  Google Scholar 

  15. Fujii K, Isozaki H, Okajima K et al (1999) Clinical evaluation of lymph node metastasis in gastric cancer defined by the fifth edition of the TNM classification in comparison with the Japanese system. Br J Surg 86:685–689

    Article  PubMed  CAS  Google Scholar 

  16. Hemaneck P (2000) The superiority of the new International Union Against Cancer and American Joint Committee on Cancer TNM staging of gastric carcinoma. Cancer 88:1763–1765

    Article  Google Scholar 

  17. Hundahl SA, Phillips JL, Menck HR (2000) National Cancer Data Base report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the “different disease” hypothesis. Cancer 88:921–932

    Article  PubMed  CAS  Google Scholar 

  18. Okusa T, Nakane Y, Boku T et al (1990) Quantitative analysis of nodal involvement with respect to survival rate after curative gastrectomy for carcinoma. Surg Gynecol Obstet 170:488–494

    PubMed  CAS  Google Scholar 

  19. Siewert JR, Bottcher FK, Stein HJ, Roder JD (1998) Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg 228:449–461

    Article  PubMed  CAS  Google Scholar 

  20. Yu W, Choi GS, Whang J et al (1997) Comparison of five systems for staging lymph node metastasis in gastric cancer. Br J Surg 84:1305–1309

    Article  PubMed  CAS  Google Scholar 

  21. Wagner PK, Ramaswamy A, Schmitz-Moormann P et al (1991) Lymph node counts in the upper abdomen: anatomical basis for lymphadenectomy in gastric cancer. Br J Surg 78:825–827

    Article  PubMed  CAS  Google Scholar 

  22. Kodera Y, Yamamura Y, Shimizu Y et al (1998) Lymph node status assessment for gastric carcinoma: is the number of metastatic lymph nodes really practical as a parameter for N categories in the TNM classification? J Surg Oncol 69:15–20

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Naoto Fukuda.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fukuda, N., Sugiyama, Y., Midorikawa, A. et al. Prognostic Significance of the Metastatic Lymph Node Ratio in Gastric Cancer Patients. World J Surg 33, 2378–2382 (2009). https://doi.org/10.1007/s00268-009-0205-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-009-0205-1

Keywords

Navigation